Floatz logo

Nitrazepam

Sleep Initiation and Maintenance Disorders

Astellas Pharma IncSmall moleculePhase 3Dormant
B
56/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
41/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Sleep Initiation and Maintenance Disorders cohort.

Asset / SponsorPhaseRating
TENOFOVIR DISOPROXIL FUMARATE
Azienda Ospedaliera San Gerardo di Monza
Phase 4BB
(±)-FTC
Azienda Ospedaliera San Gerardo di Monza
Phase 4BB
ZOLPIDEM
Astellas Pharma Inc
Phase 3BB
Suvorexant
Merck Sharp & Dohme LLC
Phase 3BB
fk199b
Astellas Pharma Inc
Phase 3BB

View all 12 →

Same molecule, other indications

Nitrazepam is also rated in:

anxiety disorderDormant
CCC
Indicative ·
54 / 100
View asset →
physiological malfunction arising from mental factorDormant
CCC
Indicative ·
54 / 100
View asset →
dementiaDormant
CCC
Indicative ·
53 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →